HOME >> BIOLOGY >> NEWS
NIH gives $8M to University of Pittsburgh School of Medicine for myositis research

PITTSBURGH, Aug. 13 Researchers from the division of rheumatology and clinical immunology at the University of Pittsburgh School of Medicine are leading a worldwide effort to study a treatment for a rare autoimmune disorder called myositis, thanks to a five-year, $8 million contract from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH).

Chester V. Oddis, M.D., professor of medicine at the University of Pittsburgh School of Medicine, is principal investigator for the effort, which involves 36 other scientists from 18 states and five countries, including Canada, the Czech Republic, Sweden, England and the United States.

Myositis is a general term for several conditions, including dermatomyositis, polymyositis, inclusion-body myositis and juvenile forms of myositis. Also known as inflammatory myopathies, they are musculoskeletal disorders characterized by muscle weakness thought to be autoimmune diseases. This means that the bodys immune system, which normally fights infections and viruses, for reasons unknown turns on itself and attacks the muscle tissue and sometimes skin, joints and lungs, causing rash, arthritis and shortness of breath.

The University of Pittsburgh-led study will evaluate the effectiveness of a drug called rituximab in adults and children diagnosed with dermatomyositis (a disease that causes muscle weakness and rash) and adults diagnosed with polymyositis, which is not associated with a rash. The study doctors want to know whether rituximab improves symptoms of these diseases.

Rituximab is a monoclonal antibody used and approved since 1997 by the Food and Drug Administration (FDA) for the treatment of B-cell non-Hodgkins lymphoma. It was approved in February 2006 for adult rheumatoid arthritis patients with an inadequate response to anti-TNF (tumor necrosis factor) agents. In this study, rituximab is considered to be experimental
'"/>

Contact: Michele Baum
BaumMD@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
13-Aug-2007


Page: 1 2

Related biology news :

1. Brain blood flow gives clues to treating depression
2. Immune system escape hatch gives cancer cells traction
3. Investigating Life in Extreme Environments report gives hints on facts of life
4. 5.9 million award gives UK aging research a new lease on life
5. Neuronal activity gives clues to working memory
6. Study of damaged gene gives insight into causes of mental illness
7. Human pubic lice acquired from gorillas gives evolutionary clues
8. DNA gives new perspectives to understand the mysteries of nature
9. NIH gives PITT $13 million grant for chronic obstructive pulmonary disease research
10. Study gives clues about how deadly bacterium gains foothold
11. Resilient form of plant carbon gives new meaning to term older than dirt

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... (PRWEB) , ... February 11, 2020 , ... ... firm, is pleased to announce it achieved its ISO 9001:2015 registration by certification ... preparation for the audits, she reviewed and revised all existing Standard Operating Procedures ...
(Date:2/11/2020)... ... February 11, 2020 , ... The LaunchPort™ announced ... accelerator in Port Covington, Baltimore. The newly formed company is developing a novel ... manage increased demand for home dialysis treatments. The start-up company will be moving ...
(Date:2/7/2020)... ... February 07, 2020 , ... dicentra , a ... product, nutraceutical and dietary supplement industries, announces 2020 membership with the International Probiotics ... and research pertaining to probiotics. We are thrilled to join our IPA member ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... , ... February 20, 2020 , ... ... supply chain transparency and reassuring consumers that what’s listed on an ingredient panel ... ingredients, Nutrition21 has introduced this solution with the adoption of CertainT, which is ...
(Date:2/19/2020)... ... February 18, 2020 , ... Shoreline Biome, ... the strain level, recently unveiled a novel DNA isolation product. , Shoreline Rapid ... of high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40 kB ...
(Date:2/13/2020)... ... February 12, 2020 , ... Arriello , a ... adopting Veeva Vault Safety™ as part of the company’s continued growth ... data, processing of safety information such as SUSARs and ICSRS, aggregate report production, ...
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced it is now registering ... Las Vegas. The course is hands on involving real patients and stem cell biologics, ... the Comprehensive Stem Cell Training Course has received rave reviews from attendees, who love ...
Breaking Biology Technology:
Cached News: